A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer

Steven C. Ames, Winston Tan, Gretchen E. Ames, Ronald L. Stone, Thomas D. Rizzo, Juliana Crook, Christopher R. Williams, Chudley E. Werch, Matthew M Clark, Teresa A. Rummans

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: This pilot project evaluated the acceptability and estimated the effect size of a tailored multidisciplinary quality of life (MQOL) intervention for men who have biochemical recurrence of prostate cancer. Methods: Participants included 57 men with localized prostate cancer with biochemical recurrence (Median=76 years; 89% White). Participants were randomized to wait list control which offered the intervention upon conclusion of the study (n=27) or to an eight-session group-based, MQOL (n=30) intervention. Assessments were completed at baseline, end of treatment, and 6 months post-treatment. Results: MQOL was acceptable as indicated by favorable participant retention (100% retained), treatment compliance (97% attended > 6 treatment sessions), and high ratings of helpfulness (80% rated helpfulness > 4 on 5-point scale). MQOL had a favorable impact on the mental health composite score of the Short Form-36 at the end of treatment but not at 6 months (effect size=0.52 and -0.04); health-related QOL as measured by the Functional Assessment of Cancer Therapy-Prostate at the end of treatment and 6 months (effect size=0.14 and 0.10); and prostate cancer specific anxiety as measured by the Memorial Anxiety Scale for Prostate Cancer at the end of treatment and 6 months (effect size=0.45 and 0.23). Conclusions: This pilot project provides preliminary data supporting the premise that a tailored behaviorally based MQOL intervention for men with biochemical recurrence of prostate cancer is acceptable to men and might reduce prostate cancer specific anxiety and enhance QOL. Further research examining the efficacy of this intervention in a larger randomized trial is warranted.

Original languageEnglish (US)
Pages (from-to)435-440
Number of pages6
JournalPsycho-Oncology
Volume20
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Prostatic Neoplasms
Quality of Life
Recurrence
Anxiety
Therapeutics
Mental Health
Health
Research

Keywords

  • cancer
  • oncology
  • pilot study
  • prostate cancer
  • quality of life

ASJC Scopus subject areas

  • Oncology
  • Psychiatry and Mental health
  • Experimental and Cognitive Psychology

Cite this

A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer. / Ames, Steven C.; Tan, Winston; Ames, Gretchen E.; Stone, Ronald L.; Rizzo, Thomas D.; Crook, Juliana; Williams, Christopher R.; Werch, Chudley E.; Clark, Matthew M; Rummans, Teresa A.

In: Psycho-Oncology, Vol. 20, No. 4, 04.2011, p. 435-440.

Research output: Contribution to journalArticle

Ames, Steven C. ; Tan, Winston ; Ames, Gretchen E. ; Stone, Ronald L. ; Rizzo, Thomas D. ; Crook, Juliana ; Williams, Christopher R. ; Werch, Chudley E. ; Clark, Matthew M ; Rummans, Teresa A. / A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer. In: Psycho-Oncology. 2011 ; Vol. 20, No. 4. pp. 435-440.
@article{321c2aa3525f47ed98313b4b9d06fb6d,
title = "A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer",
abstract = "Objective: This pilot project evaluated the acceptability and estimated the effect size of a tailored multidisciplinary quality of life (MQOL) intervention for men who have biochemical recurrence of prostate cancer. Methods: Participants included 57 men with localized prostate cancer with biochemical recurrence (Median=76 years; 89{\%} White). Participants were randomized to wait list control which offered the intervention upon conclusion of the study (n=27) or to an eight-session group-based, MQOL (n=30) intervention. Assessments were completed at baseline, end of treatment, and 6 months post-treatment. Results: MQOL was acceptable as indicated by favorable participant retention (100{\%} retained), treatment compliance (97{\%} attended > 6 treatment sessions), and high ratings of helpfulness (80{\%} rated helpfulness > 4 on 5-point scale). MQOL had a favorable impact on the mental health composite score of the Short Form-36 at the end of treatment but not at 6 months (effect size=0.52 and -0.04); health-related QOL as measured by the Functional Assessment of Cancer Therapy-Prostate at the end of treatment and 6 months (effect size=0.14 and 0.10); and prostate cancer specific anxiety as measured by the Memorial Anxiety Scale for Prostate Cancer at the end of treatment and 6 months (effect size=0.45 and 0.23). Conclusions: This pilot project provides preliminary data supporting the premise that a tailored behaviorally based MQOL intervention for men with biochemical recurrence of prostate cancer is acceptable to men and might reduce prostate cancer specific anxiety and enhance QOL. Further research examining the efficacy of this intervention in a larger randomized trial is warranted.",
keywords = "cancer, oncology, pilot study, prostate cancer, quality of life",
author = "Ames, {Steven C.} and Winston Tan and Ames, {Gretchen E.} and Stone, {Ronald L.} and Rizzo, {Thomas D.} and Juliana Crook and Williams, {Christopher R.} and Werch, {Chudley E.} and Clark, {Matthew M} and Rummans, {Teresa A.}",
year = "2011",
month = "4",
doi = "10.1002/pon.1769",
language = "English (US)",
volume = "20",
pages = "435--440",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancer

AU - Ames, Steven C.

AU - Tan, Winston

AU - Ames, Gretchen E.

AU - Stone, Ronald L.

AU - Rizzo, Thomas D.

AU - Crook, Juliana

AU - Williams, Christopher R.

AU - Werch, Chudley E.

AU - Clark, Matthew M

AU - Rummans, Teresa A.

PY - 2011/4

Y1 - 2011/4

N2 - Objective: This pilot project evaluated the acceptability and estimated the effect size of a tailored multidisciplinary quality of life (MQOL) intervention for men who have biochemical recurrence of prostate cancer. Methods: Participants included 57 men with localized prostate cancer with biochemical recurrence (Median=76 years; 89% White). Participants were randomized to wait list control which offered the intervention upon conclusion of the study (n=27) or to an eight-session group-based, MQOL (n=30) intervention. Assessments were completed at baseline, end of treatment, and 6 months post-treatment. Results: MQOL was acceptable as indicated by favorable participant retention (100% retained), treatment compliance (97% attended > 6 treatment sessions), and high ratings of helpfulness (80% rated helpfulness > 4 on 5-point scale). MQOL had a favorable impact on the mental health composite score of the Short Form-36 at the end of treatment but not at 6 months (effect size=0.52 and -0.04); health-related QOL as measured by the Functional Assessment of Cancer Therapy-Prostate at the end of treatment and 6 months (effect size=0.14 and 0.10); and prostate cancer specific anxiety as measured by the Memorial Anxiety Scale for Prostate Cancer at the end of treatment and 6 months (effect size=0.45 and 0.23). Conclusions: This pilot project provides preliminary data supporting the premise that a tailored behaviorally based MQOL intervention for men with biochemical recurrence of prostate cancer is acceptable to men and might reduce prostate cancer specific anxiety and enhance QOL. Further research examining the efficacy of this intervention in a larger randomized trial is warranted.

AB - Objective: This pilot project evaluated the acceptability and estimated the effect size of a tailored multidisciplinary quality of life (MQOL) intervention for men who have biochemical recurrence of prostate cancer. Methods: Participants included 57 men with localized prostate cancer with biochemical recurrence (Median=76 years; 89% White). Participants were randomized to wait list control which offered the intervention upon conclusion of the study (n=27) or to an eight-session group-based, MQOL (n=30) intervention. Assessments were completed at baseline, end of treatment, and 6 months post-treatment. Results: MQOL was acceptable as indicated by favorable participant retention (100% retained), treatment compliance (97% attended > 6 treatment sessions), and high ratings of helpfulness (80% rated helpfulness > 4 on 5-point scale). MQOL had a favorable impact on the mental health composite score of the Short Form-36 at the end of treatment but not at 6 months (effect size=0.52 and -0.04); health-related QOL as measured by the Functional Assessment of Cancer Therapy-Prostate at the end of treatment and 6 months (effect size=0.14 and 0.10); and prostate cancer specific anxiety as measured by the Memorial Anxiety Scale for Prostate Cancer at the end of treatment and 6 months (effect size=0.45 and 0.23). Conclusions: This pilot project provides preliminary data supporting the premise that a tailored behaviorally based MQOL intervention for men with biochemical recurrence of prostate cancer is acceptable to men and might reduce prostate cancer specific anxiety and enhance QOL. Further research examining the efficacy of this intervention in a larger randomized trial is warranted.

KW - cancer

KW - oncology

KW - pilot study

KW - prostate cancer

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=79953011700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953011700&partnerID=8YFLogxK

U2 - 10.1002/pon.1769

DO - 10.1002/pon.1769

M3 - Article

C2 - 20878861

AN - SCOPUS:79953011700

VL - 20

SP - 435

EP - 440

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

IS - 4

ER -